Home>Topics>Companies>Baxter International

Baxter International BAX

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Fitch Maintains Baxter International on Rating Watch Negative

      Headlines

      Fri, 20 Mar 2015

      March 20 (Fitch) Fitch Ratings has maintained Baxter International Inc .'s ( Baxter ; NYSE: BAX ) long- and short-term ratings on Rating ..... ratings on Negative Watch in March 2014 when Baxter announced it plans to spin off its BioScience

    2. From Barron’s, March 9, 2015 (Part 1)

      Commentary

      Sat, 7 Mar 2015

      AAPL ] joins the DJIA and AT&T [ T ] is booted out. Baxter International [ BAX ; yield 3%; fwd EV/EBITDA 10.4] is attractive ..... upcoming split into two – medical-products [to retain Baxter name] and biopharma [to be called Baxalta ]. Steakhouse

    3. Pfizer's Acquisition of Hospira Strengthens Its Moat at a Fair Price

      Headlines

      Thu, 5 Feb 2015

      half of 2015). Pfizer is gaining specialty injectable pharmaceuticals (68% of Hospira sales), which should strengthen ..... the infusion pump market, such as Fresenius SE FMS or Baxter BAX , could be interested in taking the device segment off

    4. Pfizer's Acquisition of Hospira Strengthens Its Moat at a Fair Price

      Commentary

      Thu, 5 Feb 2015

      half of 2015). Pfizer is gaining specialty injectable pharmaceuticals (68% of Hospira sales), which should strengthen the ..... in the infusion pump market, such as Fresenius SE or Baxter , could be interested in taking the device segment off

    5. Health Care: A Strong Run, but Some Stocks Still Look Undervalued

      Headlines

      Wed, 31 Dec 2014

      Uncertainty Consider Buying Baxter $84 Wide Low $67.20 ..... Data as of 12-23-14 Baxter BAX Although competition is increasing for Advate, Baxter 's highly profitable hemophilia ..... Intangible assets--like Baxter 's strong brands, patent

    6. When Boring Becomes Exciting

      Headlines

      Mon, 15 Dec 2014

      the past quarter include: ABB Ltd., Ann Inc., Baxter International , International Game Technology, TRW Automotive ..... and is subject to change: ABB Ltd., Ann Inc., Baxter International , International Game Technolgy, TRW Automotive

    7. United States Anesthesia Drugs Market & Forecast

      Commentary

      Fri, 12 Dec 2014

      maximum market share. From companies analysis part Baxter International Inc , Endo Health Solutions Inc and Abbott Laboratories ..... Profile in United States Anesthetic Drugs Market Baxter International Inc Endo Health Solutions Inc Abbott Laboratories

    8. Finding a Margin of Safety in a Fully Valued Market

      Headlines

      Fri, 21 Nov 2014

      three firms that passed the screen: Baxter BAX Current Price: $72 | Fair Value ..... think diversified health-care firm Baxter has earned a wide economic moat ..... products. Intangible assets--like Baxter 's strong brands, patent protection

    9. Baxter's 3Q Reflects Hemophilia Competitive Advantages; Well-Positioned for Plasma and Renal Growth

      Commentary

      Thu, 16 Oct 2014

      value estimate for Baxter after third-quarter results. Baxter 's revenue (excluding the vaccine business, which ..... 32. Overall, Baxter 's hemophilia franchise ..... example, Baxalta ( Baxter 's BioScience spin-off ..... proteins. The new Baxter stands to benefit ..... Biosurgery and Specialty Pharmaceuticals .

    10. Health Care: Some Healthy Bargains Still Remain

      Headlines

      Wed, 1 Oct 2014

      Narrow Medium $39.90 Baxter $84.00 Wide Low $67 ..... stock look undervalued. Baxter BAX While competition is increasing for Advate, Baxter 's highly profitable hemophilia ..... Intangible assets--like Baxter 's strong brands, patent

    « Prev12345Next »
    Content Partners